| 326 | 10 | 171 |
| 下载次数 | 被引频次 | 阅读次数 |
目的比较冻融囊胚移植周期中采用不同黄体酮制剂联合用药进行黄体支持的妊娠结局及药物费用。方法采用前瞻性随机研究,2012年10月至2013年4月在温州医科大学附属第一医院生殖中心行冻融囊胚激素替代周期的患者160例,均采用芬吗通白片先口服后阴道给药方式准备子宫内膜。按照不同的黄体支持方法随机分为3组:A组64例,采用黄体酮针剂注射(60mg每日1次)联合地屈孕酮片口服(10mg每日2次);B组50例,采用黄体酮阴道缓释凝胶阴道给药(90mg每日1次)联合地屈孕酮片口服(10mg每日2次);C组46例,采用黄体酮针剂注射(60mg每日1次)联合微粒化黄体酮软胶囊阴道给药(200mg每日2次)。两两比较A、B组及A、C组患者的妊娠结局、黄体酮药物费用。结果分别两两比较A、B组及A、C组的内膜厚度、内膜类型、开始使用孕激素日雌二醇及孕酮水平、平均移植胚胎数、种植率、生化妊娠率、临床妊娠率、多胎妊娠率、早期流产率及异位妊娠率,差异均无统计学意义(P>0.05)。B组每移植周期黄体酮药物费用1538.5元、每获得1例临床妊娠所需费用3 077元,均高于A组的261.29元、522.58元和C组的271.49元、624.73元。接受黄体酮注射患者局部红肿发生率2.7%。接受阴道缓释凝胶及微粒化软胶囊阴道给药患者出现阴道分泌物增多、伴瘙痒的发生率分别为2.0%及10.9%,差异无统计学意义(P>0.05)。接受地屈孕酮口服的患者发生轻度胃肠道不适为1.76%。结论对于冻融囊胚移植周期,联合多途径不同黄体支持方法均可获得比较满意的临床结果。相比较于给药更简便,患者舒适度高但价格较贵的黄体酮缓释凝胶联合地屈孕酮片组(B组),黄体酮针剂联合地屈孕酮片(A组)或微粒化黄体酮软胶囊组更经济(C组)。根据患者具体的经济情况、给药方式的接受度、对不适反应的认识程度来制定不同的黄体支持方案。
Abstract:Objective:To compare the outcomes and drug costs of the different protocols for luteal phase support in frozen-thawed blastocyst transfer cycle.Methods:A total of 160 infertile women received hormonal replacement treatment in frozen-thawed blastocyst transfer cycle were recruited for this prospective randomized study in Reproductive Medicine Center,the First Affiliated Hospital of Wenzhou Medical University from Oct.2012 to Apr.2013.The patients who were taken estradiol tablets for preparing the endomitrium firstly were randomly divided to three groups:64patients received intramuscular injection of progesterone(IMP)60mg/day and 10 mg oral dydrogesterone twice per day in group A;50patients received Crinone 8% vaginal gel(90mg)daily and oral dydrogesterone 10 mg twice per day in Group B;46patients used IMP 60mg/day and Utrogestan vaginal capsules 200 mg twice daily in Group C.The blastocysts were thawed and transferred 5days later.Finally,the clinical outcomes and the drug costs were evaluated among the three groups.Results:There was no significant difference in the endometrial thickness,the levels of estradiol and progesterone on the day of progesterone administration,the average number of embryo transferred,implantation rate,biochemical pregnancy rate,clinical pregnancy rate,early abortion rate,multiple pregnancy rate,ectopic pregnancy rate between Group A & Group B or Group A & C(P>0.05).The cost of progesterone was $261.29,$1 538.5and $271.49 per cycle in Group A,Group B and Group C respectively.The cost for one successful pregnancy was $3 077 in Group B,which was the highest compared with Group A($522.58)and Group C($624.73).Abort 2.7% of the patients with IMP complained redness and swelling at the injection site.In addition,2.0%of the patients with vaginal gel and10.9% of the patients with Utrogestan vaginal capsules appeared pruritus and irritation,but there was no significant difference(P>0.05).Furthermore,1.76% of the patients with oral dydrogesterone felt mild gastrointestinal discomfortable.Conclusions:All the protocols of administration of different progesterone for luteal phase support are effective in frozen-thawed blastocyst transfer cycle.Progesterone vaginal gel combined with oral dydrogesterone is convenient,comfortable but expensive.Intramuscular injection of progesterone combined with oral dydrogesterone or Utrogestan capsules is economic.Administration of different protocols for luteal phase support should depend on the patient's economic conditions,acceptance to the administration methods and adaptability to the adverse reaction.
[1]陈雅文,肖仕全,林金菊.冻融囊胚移植后临床结局分析[J].生殖医学杂志,2011,20:352-355.
[2]庄广伦.现代辅助生殖技术[M].第1版.北京:人民卫生出版社,2005:402.
[3]田甜,李艳萍,刘冬娥.激素替代周期冻融胚胎移植术的安全性评价[J].生殖医学杂志,2012,21:30-33.
[4]王晓兰,刘能辉,李艳萍,等.3种子宫内膜准备方案对冻融胚胎移植的临床结局比较[J].中国现代医学杂志,2011,21:431-434.
[5]陈芳,段华,张颖,等.不同水平雌激素在宫腔粘连形成中的作用及相关机制[J].中华妇产科杂志,2010,45:917-920.
[6]Nahoul K,Dehennin L,Jondet M,et al.Profiles of plasma estrogens,progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone[J].Maturitas,1993,16:185-202.
[7]Tourgeman DE,Slater CC,Stanczyk FZ,et al.Endocrine and clinical effects of micronized estradiol administered vaginally or orally[J].Fertil Steril,2001,75:200-202.
[8]Tourgeman DE,Gentzchein E,Stanczyk FZ,et al.Serum and tissue hormone levels of vaginally and orally administered estradiol[J].Am J Obstet Gynecol,1999,180:1480-1483.
[9]Fanchin R,Righini C,Schnauer LM,et al.Vaginal versus oral E(2)administration:effects on endometrial thickness,uterine perfusion,and contractility[J].Fertil Steril,2001,76:994-998.
[10]Simon J,Nachtigall L,Ulrich LG,et al.Endometrial safety of ultra-low-dose estradiol vaginal tablets[J].Obstet Gynecol,2010,116:876-883.
[11]耿嘉瑄,张翠莲,张少娣,等.不同内膜准备方案在冻融胚胎移植中的作用[J].现代妇产科进展,2012,9:706-708.
[12]孙青,苗金彦,陈捷,等.肌肉注射黄体酮致局部不良反应相关因素分析[J].中国药物应用与监测,2009,6:300-302.
[13]陈霞,赵军招,陈茜茜,等.黄体酮针和地屈孕酮片对子宫内膜影响的比较研究[J].医学研究杂志,2012,41:109-112.
[14]郭薇,陈薪,叶德盛,等.口服地屈孕酮对冻融胚胎移植周期临床妊娠结局的影响[J].南方医科大学学报,2013,6:861-865.
[15]李雪梅,赵坤,刘庆芝,等.地屈孕酮治疗先兆流产的临床观察[J].实用医学杂志,2007,23:1245-1246.
[16]Hill MJ,Whitcomb BW,Lewis TD,et al.Progesterone luteal support after ovulation induction and intrauterine insemination:a systematic review and meta-analysis[J].Fertil Steril,2013,100:1373-1380.
[17]连蔚,欧阳贺月.地屈孕酮预防多囊卵巢综合征患者卵泡黄素化的意义[J].亚太传统医学,2009,5:86-87.
[18]Chakravarty BN,Shirazee HH,Dam P,et al.Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology(ART)cycles:results of a randomized study[J].J Steroid Biochem Mol Biol,2005,97:416-420.
[19]Alsbjerg B,Polyzos NP,Elbaek HO,et al.Increasing vaginal progesterone gel supplementation after frozen-thawed embryo transfer significantly increases the delivery rate[J/OL].Reprod Biomed Online,2013,26:133-137.
[20]Dal Prato L,Bianchi L,Cattoli M,et al.Vaginal gel versus intramuscular progesterone for luteal phase supplementation:aprospective randomized trial[J/OL].Reprod Biomed Online,2008,16:361-367.
[21]Yanushpolsky E,Hurwitz S,Greenberg L,et al.Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles:aprospective randomized study[J].Fertil Steril,2010,94:2596-2599.
[22]Simunic V,Tomic V,Tomic J,et al.Comparative study of the efficacy and tolerability of two vaginal progesterone formulations,Crinone 8%gel and Utrogestan capsules used for luteal support[J].Fertil Steril,2007,87:83-87.
[23]龚斐,蔡素芬,卢光璃,等.两种阴道给药黄体支持药物在IVF—ET/ICSI后用药的比较研究[J].实用妇产科杂志,2012,28:199-201.
[24]Tomic V,Tomic J,Klaic DZ.Oral micronized progesterone combined with vaginal progesterone gel for luteal support[J].Gynecol Endocrinol,2011,27:1010-1013.
[25]Fanchin R,De Ziegler D,Bergeron C,et al.Transvaginal administration of progesterone[J].Obstet Gynecol,1997,90:396-401.
[26]Waren M,Biller B,Shangold M.A new clinical option for hormone replacement therapy in women with secondary amenorrhea:effect of cyclic administration of progesterone from the sustained-release vaginal gel Crinone(4%and 8%)on endometrial morphologic features and withdrawal bleeding[J].Am J Obstet Gynecol,1999,180:42-48.
基本信息:
中图分类号:R714.8
引用信息:
[1]徐芳,林佳,赵军招,等.不同黄体支持方法对冻融囊胚移植周期结局的影响[J].生殖医学杂志,2015,24(06):444-449.
2015-06-15
2015-06-15